By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mazal Plant Pharmaceuticals Inc. 



New York  New York    U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Mazal Plant Pharmaceuticals Inc. Announces Filing of Provisional Patent for Cholesterol/HDL Investigational New Drug Formulation 6/12/2008 9:41:54 AM
Mazal Plant Pharmaceuticals Inc. Announces Appointment of Dr. Michael Silver as New Scientific Director 5/30/2008 9:18:11 AM
Mazal Plant Pharmaceuticals Inc. Announces Appointment of New CEO and New Corporate Counsel 5/21/2008 2:54:05 PM
Mazal Plant Pharmaceuticals Inc. Announced Today The Appointment Of Mr. Stanley Fass As Interim President And Director 1/22/2007 10:27:15 AM
Mazal Plant Pharmaceuticals Inc. Announces Appointment Of Richard Serbin As Head Of Business Advisory Board 10/12/2006 10:50:47 AM
Mazal Plant Pharmaceuticals Inc. Release: Dr. Robert Siegel Appointed As Scientific Director 9/21/2006 3:17:40 PM
Mazal Plant Pharmaceuticals Inc.'s Investigational New Drug Application Approved For Botanical HDL Cholesterol Elevating Drug, MAHDL 8/9/2006 12:17:47 PM
Advanced Plant Pharmaceuticals, Inc. (APPI) And Subsidiary, Mazal Plant Pharmaceuticals Inc., File Investigational New Drug Application With FDA For Cholesterol-Lowering Drug10/19/2005 5:12:50 PM
Advanced Plant Pharmaceuticals, Inc. (APPI) Today Announced That It Had Sold Its 7 Million Shares In Mazal Plant Pharmaceuticals Inc. For 20 Million Shares In Akid Corporation10/19/2005 5:11:57 PM
Advanced Plant Pharmaceuticals, Inc.'s (APPI) Majority Owned Subsidiary, Mazal Plant Pharmaceuticals Inc., Receives Investigational New Drug Application Approval From The {2} For HDL/Cholesterol Improvement Drug10/19/2005 5:09:54 PM
//-->